EPEmcure Pharmaceuticals544210Board meeting scheduled

Board meeting on November 03, 2026 to approve Unaudited Results for quarter and half-year ended September 30, 2026

Emcure Pharmaceuticals has informed the exchanges that its Board of Directors will meet on Tuesday, November 03, 2026.

By ScoutQuest · Wed 14 Oct 2026, 4:42 PM IST · 1 min read

Board Meeting Date

Tuesday, November 03, 2026

Meeting Purpose

consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026

Trading Window Closure

closed from October 01, 2026 till November 05, 2026

What the company informed the exchanges

Emcure Pharmaceuticals Limited has informed NSE and BSE that a meeting of its Board of Directors is scheduled to be held on Tuesday, November 03, 2026.

The stated purpose of the meeting is to consider and approve the Unaudited Financial Results, both Standalone and Consolidated, for the quarter and half-year ended September 30, 2026.

Why a board meeting intimation matters

• It gives investors advance notice of the date on which the Board will take up the quarterly and half-yearly results.
• The results, once approved by the Board, are what shareholders and the market normally look at for the period.
• It also tells investors the period covered: the quarter and half-year ended September 30, 2026.

Trading window

• The trading window for dealing in the securities of the company by Designated Persons and their relatives was already closed from October 01, 2026.
• It will remain closed till 48 hours after the declaration of the Unaudited Financial Results, that is till November 05, 2026.
• This closure applies to Designated Persons and their relatives under the company's Code of Conduct for regulating, monitoring and reporting of insider trading in securities.

What this means for a retail investor

The intimation fixes the date on which the Board will consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. Shareholders can note the date to know when the numbers for this period come up for the Board's approval.

Investor takeaway

This is a date-setting announcement ahead of the Board meeting. It is a scheduled event intimation, and it carries no financial figures for the quarter or half-year by itself.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev